Patient Care
Ambulances specially tailored to respond to cardiac emergencies will go into service in Goa, India, at the beginning of 2018.
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Heart failure
November 3, 2017
November 3, 2017
Kamperidis and colleagues report that left ventricular (LV) functional recovery after mitral valve (MV) repair for severe secondary mitral regurgitation is associated with improved patient outcomes.
October 27, 2017
A measured succinct reflection on MagLev and older ventricular assist devices, on the occasion of a relevant 'expert opinion' paper on the topic.
October 20, 2017
Patient Care
The “I Love Life” campaign to raise awareness of heart failure in Egypt launched this week.
October 12, 2017
The Impella RP device was approved by the FDA for use as a temporary percutaneous assist for the right ventricle, as announced by Abiomed. Use is approved for up to 14 days for a variety of indications including post MI, heart transplant, open heart surgery, or right heart failure after LVAD implant.
October 2, 2017
In this Masters of Cardiothoracic Surgery, Meier and colleagues outline their approach to transmitral myectomy and surgical management of systolic anterior motion in a case vignette of a 45-year-old male with hypertrophic cardiomyopathy.
September 29, 2017
Patient Care
A Brazilian woman ran a road race in Rio de Janiero, powered by the transplanted heart of a German Olympian that she had received only a year earlier.
September 19, 2017
The authors queried the UNOS heart transplantation database to determine if LVAD device-related complications (DRCs) were associated with worse postoperative graft survival. The 5 categories of DRCs were as follows: device thrombosis, infection, device malfunction, life-threatening arrhythmias, and others.
September 14, 2017
This study details the short- and long-term outcomes for more than 3,000 patients who underwent septal myectomy for hypertrophic cardiomyopathy at the Mayo Clinic in Rochester, United States, from 1993 to 2016.
September 9, 2017
The authors have concluded from a meta-analysis of over 45,000 patients, mitral regurgitation in the presence of LV dysfunction (either ischaemic cardiomyopathy or idiopathic causes) is, not surprisingly, associated with reduced survival. Whether this is due to the underlying myopathic process or the MR per se is not clear.